Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 20, 2020European Respiratory Journal

C1-esterase inhibitor treatment for antibody-mediated rejection after lung transplantation: two case reports

View Full Paper
Ask AI
Bookmark
Share

Authors

FPFrançois ParquinHôpital FochÉCÉ. CuquemelleSorbonne UniversitéÈCÈve CampsHôpital Foch

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Parquin et al. (2020) studied this question.

synapsesocial.com/papers/6ab8dfd4751961c586e9691bhttps://doi.org/10.1183/13993003.02027-2019
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Donor-specific HLA antibody-mediated complement activation is a significant indicator of antibody-mediated rejection and poor long-term graft outcome during lung transplantation: a single center cohort study2018 · 22 citations
  2. 2Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment2017 · 118 citations
  3. 3Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot Study2016 · 170 citations
  4. 4Antibody-mediated rejection despite inhibition of terminal complement2014 · 67 citations
  5. 5Antibody-Mediated Rejection in Lung Transplantation: Clinical Outcomes and Donor-Specific Antibody Characteristics2016 · 146 citations